TODD STYLES: Open Payments
NPI 1841767340 · EUGENE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$593 in 20 payments from 7 companies in 2025. Trend: 2023 $19 · 2024 $514 · 2025 $593
Food & beverage: $593
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 7 | $233 |
| Otsuka America Pharmaceutical, Inc. | 5 | $100 |
| ABBVIE INC. | 1 | $98 |
| Alkermes, Inc. | 4 | $85 |
| Teva Pharmaceuticals USA, Inc. | 1 | $35 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
Products named: COBENFY, VRAYLAR, ARISTADA, REXULTI, UZEDY, Jornay PM, ABILIFY ASIMTUFII, ABILIFY MAINTENA.
Industry payments across OR — which companies pay providers there.
